Eric Nuremberger
40PUBLICATIONS
79CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (40)
Sort by Publication Date:
|Feb 12, 2026
Predicting early bactericidal activity of tuberculosis drug combinations using a translational pharmacokinetic-pharmacodynamic modeling approach.Niurys de Castro Suarez, Eric L Nuermberger, Jacqueline Ernest
|Oct 22, 2025
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.Clara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas
|Jun 18, 2025
Erratum for Singh et al., "Repurposing drugs to advance the treatment of Buruli ulcer".Sanjay Singh, Rie Yotsu, Eric Nuermberger
|Jun 02, 2025
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis.Veronique de Jager, Laurynas Mockeliunas, Huifang You
|Apr 23, 2025
The KasA inhibitor JSF-3285 improves the sterilizing activity of bedaquiline-pretomanid-containing regimens in a mouse model of tuberculosis.Heena Soni, Sandeep Tyagi, Kishor Mane
|Apr 22, 2025
Efficacy of novel regimens targeting oxidative phosphorylation in Mycobacterium tuberculosis.Dongshuo Li, Liang Li, Ye Zhang
Pageof 7
Frequent Collaborators
8 joint publications
Radojka M Savic
7 joint publications
Nicole C Ammerman
5 joint publications
Jacqueline P Ernest
3 joint publications
Rob Christiaan van Wijk
3 joint publications
Jian Xu
3 joint publications
Amit Kaushik
3 joint publications
Kelly E Dooley
3 joint publications
Nan Zhang
3 joint publications
David Barros-Aguirre
3 joint publications
Gregory T Robertson
